Page last updated: 2024-08-24

nafagrel and Acute Promyelocytic Leukemia

nafagrel has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homma, M; Ichikawa, Y; Kameda, H; Yoshida, T1

Other Studies

1 other study(ies) available for nafagrel and Acute Promyelocytic Leukemia

ArticleYear
Thromboxane A2 synthase inhibitor, DP-1904, decreases TNF alpha secretion from monocytes and inhibits E-selectin and ICAM-1 expression on the endothelial cell surfaces.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Line; Cell Membrane; Cells, Cultured; E-Selectin; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Intercellular Adhesion Molecule-1; Leukemia, Promyelocytic, Acute; Monocytes; Tetrahydronaphthalenes; Thromboxane-A Synthase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins

1995